| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA794: Diroximel fumarate for treating relapsing-remitting multiple sclerosis |
|
Medicine details |
|
| Medicine name | diroximel fumarate (Vumerity®) |
| Formulation | 231 mg hard capsule |
| Reference number | 4183 |
| Indication | Treatment of adult patients with relapsing remitting multiple sclerosis |
| Company | Biogen Idec Ltd |
| BNF chapter | Central nervous system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 17/11/2021 |
| NICE guidance | TA794: Diroximel fumarate for treating relapsing-remitting multiple sclerosis |
| Commercial arrangement | PAS |